← Back

Magnera Corp placeholder

Magnera Corporation manufactures and sells non-woven and related products worldwide. Its products serve primarily consumer-oriented end markets such as healthcare and personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers, and adult incontinence products. The company also offers tea bags, coffee filters, and cable wrap. It is headquartered in Charlotte, North Carolina.

Country
Price · split & dividend adjusted
News & notes moving MAGN
MAGN

Magnera Q3 2026 Earnings: Revenue Up 2%, Adjusted EBITDA Up 9%

Magnera Corporation reported third-quarter fiscal 2026 net sales of $857 million, a 2% increase from $839 million in the prior-year period, driven by favorable foreign currency and organic volume growth. Non-GAAP adjusted EBITDA rose 9% to $99 million from $91 million a year earlier, helped by a favorable price cost spread of $11 million. The company reaffirmed its full-year free cash flow guidance of $90 million to $110 million but now expects adjusted EBITDA to finish toward the lower end of its previous range, citing persistent inflationary pressures and macroeconomic uncertainty. Americas adjusted EBITDA increased 16% to $71 million, while Rest of World adjusted EBITDA declined 7% to $28 million due to regional inflation and pricing timing lags in Europe. Management highlighted the launch of the Universa industrial wiper line and said merger synergies and Project CORE benefits of $20 million in additional run rate are expected to carry over into fiscal 2027.
The Motley Fool·36dRead more →
MAGN2

Magnera posts strongest quarter since formation with $857 million revenue

Magnera reported its strongest quarter since formation, with fiscal third-quarter revenue of $857 million and adjusted EBITDA of $99 million, up 9% year over year. Organic sales grew 1%, led by wipes and infrastructure products, while Americas adjusted EBITDA rose 16% to $71 million. The company maintained its full-year free-cash-flow outlook of $90 million to $110 million but expects adjusted EBITDA near the low end of its prior range, citing persistent inflation and macroeconomic uncertainty. Magnera also lowered expected annual capital expenditures to about $60 million and anticipates roughly $20 million of run-rate synergies and Project CORE benefits to carry into fiscal 2027.
MarketBeat·41dRead more →